©2014 Topcon Corporation 33
SIC: Enhance new business with strong basis of surveying instruments ECC: Strengthen Prognostic Management and Treatment Segment by enforcing competitiveness of Examination/Diagnosis Segment
Ⅰ. Mid-Term Business Plan 2016 Ⅰ-1. Vision for Mid-Term Business Plan Ⅰ-2. Strategic Plans on Mid-Term Business Plan Ⅰ-3. Financial Targets
POC: Accelerating IT Construction and IT Agriculture with strong GNSS core technology
Ⅰ-4. Strategic Plans by Companies
©2014 Topcon Corporation
Expand Business Field
Preventive Medicine / Physical check-up
Treatment/ Prognostic
Management Examination Diagnostic
Expansion of Business Field
Current Business Field
Ophthalmic IT
34
Strengthen Preventive Medicine and Treatment Segment by Enhancing the Strong Competitive of Examination/Diagnosis Segment
Sharing data with Cloud System and providing regional Medical cooperation service
Business Domain
©2014 Topcon Corporation
0
100
200
300
400
2012 2013 2020
World population Under 15 y (Ratio of population) Over 65 y (Ratio of population)
(Unit: Million people)
Business Environment <Global trend>
Progress in ageing society/Increase 3 major ophthalmic diseases
Source the authority: United Nations Report
(unit: Million people)
Diabetic Retinopathy AMD Glaucoma
87 90
110
127 131 161
74 75 80
Source the authority: Market Scope and Topcon’s estimation
35
(Global)
©2014 Topcon Corporation
New Business OCT Sales
OCT Business Achievement and Target New business field
Current ophthalmology field
2013 2016 2012 2011
Imaging devices w/ Screening Treatment/Prognostic management
Launching OCT Maestro (Fully automatic operation for
everyone)
Launching OCT Atlantis (World-first deep-range
scanning) 180% growth
160% growth
36
©2014 Topcon Corporation
・ OCT makes various diseases visible →Create new added value by OCT+ Functional imaging
New Business OCT Sales 〈New business development〉
Major Strategy
◆Market size: 30 billion yen ◆Increasing ophthalmic diseases accompanying of ageing ・Diabetic Retinopathy ・AMD ・Glaucoma etc. ◆OCT market acceleratory expands from ophthalmology to Screening
Disruptive innovation generates additional value
New product (under development)
Make various diseases visible
2012年度 2013年度 2016年度
160%
OCT angiography
37
Market Potential
Sales Projection
FY2012 FY2013 FY2016
©2014 Topcon Corporation
2012年度 2013年度 2016年度
・Realize Smart Prognostic Management System by utilize CLOUD service Capture images at distant area →Diagnostic at hospital→Send report
New Business OCT Sales <Create Prognostic Business>
Major Strategy
◆Market size: 30 billion yen ◆Increasing patients accompanying of aging, improving diagnostic efficiency, and solving shortage of physicians ◆Expand follow-up needs by popularization of Anti-VEGF injections
Create Prognostic Management business by OCT with fully automatic operation
Follow up→ attend a hospital when treatment needed
Any Data Any Device Any Time Any Place
38
OCT with fully automatic operation device in prognostic management
World’s First
Sales Projection
Market Potential
FY2012 FY2013 FY2016
©2014 Topcon Corporation
・Expand physical check-up market by OCT (Improve reading efficacy) ・Offering Screening System by CLOUD service
New Business OCT Sales <Entering screening market>
Major Strategy
◆Market size: 82 billion yen ◆Increasing patients accompanying of ageing, Improve diagnostic efficiency/Solve shortage of physicians ◆Provide premium service even if at distant area
Expand Screening business by OCT with fully automatic operation
Local healthcare network
2012年度 2013年度 2016年度
200%
Any Data Any Device Any Time Any Place
Advanced analysis by CLOUD (Joint Lab with )
Screening by OCT with fully automatic operation
39
World’s First
Sales Projection
FY2012 FY2013 FY2016
Market Potential
©2014 Topcon Corporation
・Integration of Pattern laser & OCT for Treatment/ Prognostic Management ・Provide treatment device better tolerated by patient (less- pain/burden)
New Business Expand Treatment Device
Major Strategy
◆Market size: 70 billion yen ◆Increase in Diabetic retinopathy and Aged-related macular degeneration ◆Complex treatment by Laser + Anti-VEGF
Create synergy with Treatment & Retinal Imaging devices 180%
40
Treatment/ Prognostic Management
2012年度 2013年度 2016年度 Prognostic Management by
OCT with ease of use
Launching new product
Sales Projection
Market Potential
FY2012 FY2013 FY2016
©2014 Topcon Corporation
Strengthen Countermeasures to FDA
1 2
1
6
7
2010 2011 2012 2013 2014
Topcon FDA510(k) Trend for number of clearance models
・Enforce the capability for regulation of medical device in globally -Enforce organization for FDA regulation (Adopted 6 staffs who has a strong skill for FDA in U.S.) -Increase the number of Clearance: 1 model (FY2012)→ 7 models (expected in FY2014)
Enforce the capability for severe FDA condition
Enforce the organization Adopt FDA specialist
“T-GREAT”(Topcon-Global Regulatory Executive Affairs Team)
41
©2014 Topcon Corporation 42
FY2013 (Result)
FY2014 - FY2016 (Plan)
Strategic Product 3 models 10 models
Reduction of COGS 6 models 6 models
Products for emerging markets 0 model 4 Models
Total 9 Models 20 Models
New Products Launch
©2014 Topcon Corporation
Breakdown of Sales Growth
Examination/Diagnostic
Treatment/ Prognostic
Management
38.7
50.5
Preventive/ Check up
Eye Care Company
New Business (Preventive/Checkup, Treatment/Prognostic Management, Ophthalmic IT)
Core Business (Examination/Diagnostic)
43
FY 2013 Result Mid-term Plan 2016
(unit: billion yen)
Operating Income Ratio 10.3%
Operating Income Ratio 16.8%